Skip to main content
. 2022 Mar 25;2022:6097221. doi: 10.1155/2022/6097221

Figure 5.

Figure 5

Decrease in intrahepatic cccDNA and histological Response. (a) The cccDNA in the liver at the baseline and at the end of the trial. (b) The Scheuer necroinflammatory grade and the fibrosis stage at the baseline and at the end of the trial.  p < 0.05.